Cargando…
A prospective comparative study of intravenous alendronate and ibandronate for the treatment of osteoporosis
RATIONALE: Few comparative studies have evaluated the differences between intravenous alendronate (ALN) and ibandronate (IBN) in patients with osteoporosis. This study was to compare the effects of these 2 drugs on bone mineral density (BMD), bone metabolic markers, and adverse events in patients wi...
Autores principales: | Horikawa, Akira, Miyakoshi, Naohisa, Hongo, Michio, Kasukawa, Yuji, Kodama, Hiroyuki, Shimada, Yoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380741/ https://www.ncbi.nlm.nih.gov/pubmed/30732159 http://dx.doi.org/10.1097/MD.0000000000014340 |
Ejemplares similares
-
A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis
por: Horikawa, Akira, et al.
Publicado: (2015) -
The Effects of Trends in Osteoporosis Treatment on the Incidence of Fractures
por: Horikawa, Akira, et al.
Publicado: (2021) -
Treatment of spontaneous osteonecrosis of the knee by daily teriparatide: A report of 3 cases
por: Horikawa, Akira, et al.
Publicado: (2020) -
Effects of eldecalcitol and ibandronate on secondary osteoporosis and muscle wasting in rats with adjuvant-induced arthritis
por: Ono, Yuichi, et al.
Publicado: (2018) -
A prospective analysis of concentration of 25-OHD between northern and southern district in Japan in year-round study
por: Horikawa, Akira, et al.
Publicado: (2022)